• Empty Cart
    • عربي عربي
روشتة
  1. Home 1
  2. Medicines2
  3. glyxambi 25/5 mg tablets25/5 mg3

glyxambi 25/5 mg tablets

product image

  • Scientific Name: EMPAGLIFLOZIN , LINAGLIPTIN
  • Dosage: 25/5 mg
  • Type: Tablets

Price: 18.00 OMR | OMR


Buy the medicine
Saudi Arabia UAE Oman


    Medicine Description

    glyxambi for the treatment of type 2 diabetes. glyxambi contains the active ingredient empaglifosin and linagliptin.




    latest articles

    • comparison of the differences between cutivate and betaderm and the best for skin infections
    • Comparison of the difference between Losartan and Furosemide tablets for hypertension treatment
    • Clarimycin tabelts 250 mg
    • nandurabolin 50 mg/ml ampoules
    • Sinusitis symptoms and treatment methods
    • Comparison of the difference between Iruxol and Skinatra ointments and which is better for scars healing




    Related medicines

    empacoza 10mg tablets 10mg
    empacoza 10mg tablets 10mg | Tablets
    mellitofix trio 30 tablets 10/5/1000 mg 10/5/1000 mg
    mellitofix trio 30 tablets 10/5/1000 mg 10/5/1000 mg | Tablets
    glimpacare 25 mg tablets 25 mg
    glimpacare 25 mg tablets 25 mg | Tablets
    synjardy 12.5/1000mg tablets 12.5/1000mg
    synjardy 12.5/1000mg tablets 12.5/1000mg | Tablets

    Latest medicines

    disflatyl 40 mg 30 chew. tabs 40 mg
    disflatyl 40 mg 30 chew. tabs 40 mg | Tablets
    bisadyl 5 mg supp 5 mg
    bisadyl 5 mg supp 5 mg | Supp
    Colistin 20 tablets
    Colistin 20 tablets | Tablets
    cetrotide 0.25 mg 1 vial 0.25 mg
    cetrotide 0.25 mg 1 vial 0.25 mg | Vial
    Checkout
    Cart :

    Back

    Cart

    • About Us
    • Rosheta
    • Privacy Policy
    • terms of services
    • Gastrointestinal
    • Respiratory System
    • Articles
    • Medicines
    • General Medicine
    • Antodine
    • Controloc
    • Maxilase
    • Call Us

    © 2025 All Rights Reserved Rosheta - Developed By Rosheta

    Login Or Register

    Login Or Register

    By registering, you agree on Our terms & Conditions.